Suchergebnisse - "Genovese, M C"

PubPharm (62)

1

Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2017

von Kivitz, A. | Gutierrez-Ureña, S. | Poiley, J. | +6

2

Peficitinib, a JAK Inhibitor, in the Treatment of Moderate‐to‐Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate

enthalten in: Arthritis & Rheumatology | 2017

von Kivitz, A. | Gutierrez‐Ureña, S. | Poiley, J. | +6

3

Tolérance et efficacité à 5 ans d’abatacept sous-cutané chez des patients présentant une PR modérée à sévère et une réponse inadéquate au MTX : extension à long terme de l’étude de phase III, randomisée et en double aveugle ACQUIRE

enthalten in: Revue du rhumatisme / Edition française | 2016

von Durez, P. | Genovese, M. | Tena, C. | +15

4

Tabalumab in rheumatoid arthritis patients with an inadequate response to methotrexate and naive to biologic therapy : a phase II, randomized, placebo-controlled trial

enthalten in: Arthritis and rheumatism | 2013

von Genovese, M. | Bojin, S. | Biagini, I. | +5

5

Tabalumab in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate and Naive to Biologic Therapy: A Phase II, Randomized, Placebo‐Controlled Trial

enthalten in: Arthritis & rheumatism | 2013

von Genovese, M. | Bojin, S. | Biagini, I. | +5

6

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor : results of a forty-eight–week randomized, double-blind, placebo-controlled, parallel-group phase III trial

enthalten in: Arthritis and rheumatism | 2012

von Tak, P. | Mease, P. | Genovese, M. | +9

7

Safety and efficacy of ocrelizumab in patients with rheumatoid arthritis and an inadequate response to at least one tumor necrosis factor inhibitor: Results of a forty‐eight–week randomized, double‐blind, placebo‐controlled, parallel‐group phase III trial

enthalten in: Arthritis & rheumatism | 2012

von Tak, P. | Mease, P. | Genovese, M. | +9

8

Subcutaneous abatacept versus intravenous abatacept : a phase IIIb noninferiority study in patients with an inadequate response to methotrexate

enthalten in: Arthritis and rheumatism | 2011

von Genovese, M. | Covarrubias, A. | Leon, G. | +15

CommentIn: J Rheumatol. 2015 Oct;42(10):1994. - PMID 26429208

9

Subcutaneous abatacept versus intravenous abatacept: A phase IIIb noninferiority study in patients with an inadequate response to methotrexate

enthalten in: Arthritis & rheumatism | 2011

von Genovese, M. | Covarrubias, A. | Leon, G. | +15

10

Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy : results of a phase II, randomized, placebo-controlled, dose-finding trial

enthalten in: Arthritis and rheumatism | 2011

von Genovese, M. | Kinnman, N. | de La Bourdonnaye, G. | +2

CommentIn: Nat Rev Rheumatol. 2011 Jun;7(6):313. - PMID 21637311

1
2
3
4
5
6
7
Nächster »
[7]